219 related articles for article (PubMed ID: 25840795)
1. Synthesis, crystal structures, and urease inhibition of an acetohydroxamate-coordinated oxovanadium(V) complex derived from N'-(3-bromo-2-hydroxybenzylidene)-4-methoxybenzohydrazide.
Qu D; Niu F; Zhao X; Yan KX; Ye YT; Wang J; Zhang M; You Z
Bioorg Med Chem; 2015 May; 23(9):1944-9. PubMed ID: 25840795
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, structures and urease inhibitory activity of cobalt(III) complexes with Schiff bases.
Jing C; Wang C; Yan K; Zhao K; Sheng G; Qu D; Niu F; Zhu H; You Z
Bioorg Med Chem; 2016 Jan; 24(2):270-6. PubMed ID: 26712097
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structures and Helicobacter pylori urease inhibitory activity of copper(II) complexes with tridentate aroylhydrazone ligands.
Pan L; Wang C; Yan K; Zhao K; Sheng G; Zhu H; Zhao X; Qu D; Niu F; You Z
J Inorg Biochem; 2016 Jun; 159():22-8. PubMed ID: 26908284
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Crystal Structures of Benzohydroxamate-Coordinated Vanadium(V) Oxo Complexes with Aroylhydrazone Ligands.
Qian SS; Zhao X; Wang J; You Z
Acta Chim Slov; 2015; 62(4):828-33. PubMed ID: 26680710
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, inhibitory activity and molecular docking studies of two Cu(II) complexes against Helicobacter pylori urease.
Cui YM; Dong XW; Chen W; Wang WJ; Li YG; Zhu HL
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):528-32. PubMed ID: 22809106
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Crystal Structures and Urease Inhibition of N'-(2-Bromobenzylidene)-2-(4-nitrophenoxy) acetohydrazide and N'-(4-Nitrobenzylidene) -2-(4-nitrophenoxy)acetohydrazide.
Sheng GH; Chen XF; Li J; Chen J; Xu Y; Han YW; Yang T; You Z; Zhu HL
Acta Chim Slov; 2015; 62(4):940-6. PubMed ID: 26680723
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation, and molecular docking studies of 2,5-substituted-1,4-benzoquinone as novel urease inhibitors.
You ZL; Xian DM; Zhang M; Cheng XS; Li XF
Bioorg Med Chem; 2012 Aug; 20(16):4889-94. PubMed ID: 22824761
[TBL] [Abstract][Full Text] [Related]
8. Structural study of ribonucleotide reductase inhibitor hydrazones. Synthesis and X-ray diffraction analysis of a copper(II)-benzoylpyridine-2-quinolinyl hydrazone complex.
Tamasi G; Chiasserini L; Savini L; Sega A; Cini R
J Inorg Biochem; 2005 Jun; 99(6):1347-59. PubMed ID: 15869799
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Crystal Structures and Urease Inhibition of 4-Bromo-N'-(1-(pyridin-2-yl)ethylidene)benzohydrazide and Its Dinuclear Copper(II) Complex.
Zhao H; Liu XR; Wang X; Hu J; Cai YJ; Peng QA
Acta Chim Slov; 2021 Dec; 68(4):804-810. PubMed ID: 34918762
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structures and urease inhibition studies of Schiff base metal complexes derived from 3,5-dibromosalicylaldehyde.
Cui Y; Dong X; Li Y; Li Z; Chen W
Eur J Med Chem; 2012 Dec; 58():323-31. PubMed ID: 23142672
[TBL] [Abstract][Full Text] [Related]
11. Vanadium complexes having [VO]2+, [VO]3+ and [VO2]+ cores with hydrazones of 2,6-diformyl-4-methylphenol: synthesis, characterization, reactivity, and catalytic potential.
Maurya MR; Haldar C; Kumar A; Kuznetsov ML; Avecilla F; Costa Pessoa J
Dalton Trans; 2013 Sep; 42(33):11941-62. PubMed ID: 23680862
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(IV), oxovanadium(V) and mu-bis(oxo)bis{oxovanadium(V)} complexes.
Maurya MR; Agarwal S; Abid M; Azam A; Bader C; Ebel M; Rehder D
Dalton Trans; 2006 Feb; (7):937-47. PubMed ID: 16462954
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.
Xiao ZP; Peng ZY; Dong JJ; He J; Ouyang H; Feng YT; Lu CL; Lin WQ; Wang JX; Xiang YP; Zhu HL
Eur J Med Chem; 2013 May; 63():685-95. PubMed ID: 23567958
[TBL] [Abstract][Full Text] [Related]
14. The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections.
Ni WW; Liu Q; Ren SZ; Li WY; Yi LL; Jing H; Sheng LX; Wan Q; Zhong PF; Fang HL; Ouyang H; Xiao ZP; Zhu HL
Bioorg Med Chem; 2018 Aug; 26(14):4145-4152. PubMed ID: 29983280
[TBL] [Abstract][Full Text] [Related]
15. Ternary oxovanadium(IV) complexes with amino acid-Schiff base and polypyridyl derivatives: synthesis, characterization, and protein tyrosine phosphatase 1B inhibition.
Lu L; Yue J; Yuan C; Zhu M; Han H; Liu Z; Guo M
J Inorg Biochem; 2011 Oct; 105(10):1323-8. PubMed ID: 21864810
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.
Xiao ZP; Peng ZY; Dong JJ; Deng RC; Wang XD; Ouyang H; Yang P; He J; Wang YF; Zhu M; Peng XC; Peng WX; Zhu HL
Eur J Med Chem; 2013 Oct; 68():212-21. PubMed ID: 23974021
[TBL] [Abstract][Full Text] [Related]
17. Photocytotoxic oxovanadium(IV) complexes showing light-induced DNA and protein cleavage activity.
Sasmal PK; Saha S; Majumdar R; Dighe RR; Chakravarty AR
Inorg Chem; 2010 Feb; 49(3):849-59. PubMed ID: 20039725
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of urease activity but not growth of Helicobacter pylori by acetohydroxamic acid.
Goldie J; Veldhuyzen van Zanten SJ; Jalali S; Richardson H; Hunt RH
J Clin Pathol; 1991 Aug; 44(8):695-7. PubMed ID: 1890207
[TBL] [Abstract][Full Text] [Related]
19. The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.
Xiao ZP; Ma TW; Fu WC; Peng XC; Zhang AH; Zhu HL
Eur J Med Chem; 2010 Nov; 45(11):5064-70. PubMed ID: 20801557
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, structures, and urease inhibitory activities of three copper(II) and zinc(II) complexes with 2-{[2-(2-hydroxyethylamino)ethylimino]methyl}-4-nitrophenol.
You ZL; Ni LL; Shi DH; Bai S
Eur J Med Chem; 2010 Jul; 45(7):3196-9. PubMed ID: 20362357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
